DRUG Bright Minds Biosciences Inc. - common stock
$67.60
Price · Jul 2, 2026
52W Range
$24–$124
44% of range
Analyst Rating
STRONG BUY
7 analysts
Price Target
$165
+145% upside
P/E (TTM)
—
ROE
—
Net Profit Margin
—
DRUG Stock Snapshot Price, market cap, P/E, EPS, ROE, debt/equity, 52-week range
Price
$67.60
Market Cap
—
P/E (TTM)
—
EPS (TTM)
—
Revenue (TTM)
—
Div Yield
—
ROE
—
Debt/Equity
—
52W Range
$24 – $124
DRUG Stock Price Chart Daily OHLCV with technical indicators — pan, zoom, and customize your view
Configure
10-Year Performance Revenue, net income, margins and EPS trends
Revenue & Net Income
—
EPS
—
Free Cash Flow
—
Margins
—
Valuation P/E, P/S, P/B, EV/EBITDA ratios — is the stock expensive or cheap?
Metric
5Y trend
DRUG
Peer Median
Profitability Gross, operating and net margins; ROE, ROA, ROIC
Metric
5Y trend
DRUG
Peer Median
Financial Health Debt, liquidity, solvency — balance sheet strength
Metric
5Y trend
DRUG
Peer Median
Growth Revenue, EPS and net income growth: YoY, 3Y CAGR, 5Y CAGR
Metric
5Y trend
DRUG
Peer Median
Capital Efficiency Asset turnover, inventory turnover, receivables turnover
Metric
5Y trend
DRUG
Peer Median
DRUG Analyst Consensus Bullish and bearish analyst opinions, 12-month price target, upside
BUY
7 analysts
- Strong Buy 3 42.9%
- Buy 3 42.9%
- Hold 1 14.3%
- Sell 0 0.0%
- Strong Sell 0 0.0%
12-Month Price Target
3 analysts · 2026-07-04
Median
$141.97
Mean
$165.50
← Below all targets
$67.60
Low
$141.25
High
$213.27
Median target
$141.97
+110.0%
Mean target
$165.50
+144.8%
Peer Comparison Key metrics vs sector peers
| Ticker | Market Cap | P/E | Rev YoY | Net Margin | ROE | Gross Margin |
|---|---|---|---|---|---|---|
| DRUG | — | — | — | — | — | — |
| CGEM | $624M | -3.2 | — | — | -44.0% | — |
| OLMA | $2.03B | -13.4 | — | — | -39.4% | — |
| SANA | $1.09B | -4.2 | — | — | -172.3% | — |
| SLDB | $445M | -2.8 | — | — | -79.5% | — |
| KURA | $913M | -3.3 | 25.2% | -413.0% | -116.2% | — |
| AVTX | $336M | -3.1 | -86.6% | -132642.4% | -83.4% | — |
| REPL | $633M | -2.3 | — | — | -146.2% | — |
| JANX | $833M | -7.5 | -5.5% | -1136.2% | -11.7% | — |
| ANNX | $750M | -3.7 | — | — | -100.7% | — |
My Metrics Your personal watchlist — selected rows from Full Fundamentals
📊
Pick the metrics that matter to you — click the ➕ next to any row in Full Fundamentals above.
Your selection is saved and follows you across all tickers.